author_facet Fayette, Jérôme
Fontaine-Delaruelle, Clara
Ambrun, Alexis
Daveau, Clémentine
Poupart, Marc
Ramade, Antoine
Zrounba, Philippe
Neidhardt, Eve-Marie
Péron, Julien
Diallo, Alpha
Céruse, Philippe
Fayette, Jérôme
Fontaine-Delaruelle, Clara
Ambrun, Alexis
Daveau, Clémentine
Poupart, Marc
Ramade, Antoine
Zrounba, Philippe
Neidhardt, Eve-Marie
Péron, Julien
Diallo, Alpha
Céruse, Philippe
author Fayette, Jérôme
Fontaine-Delaruelle, Clara
Ambrun, Alexis
Daveau, Clémentine
Poupart, Marc
Ramade, Antoine
Zrounba, Philippe
Neidhardt, Eve-Marie
Péron, Julien
Diallo, Alpha
Céruse, Philippe
spellingShingle Fayette, Jérôme
Fontaine-Delaruelle, Clara
Ambrun, Alexis
Daveau, Clémentine
Poupart, Marc
Ramade, Antoine
Zrounba, Philippe
Neidhardt, Eve-Marie
Péron, Julien
Diallo, Alpha
Céruse, Philippe
Oncotarget
Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
Oncology
author_sort fayette, jérôme
spelling Fayette, Jérôme Fontaine-Delaruelle, Clara Ambrun, Alexis Daveau, Clémentine Poupart, Marc Ramade, Antoine Zrounba, Philippe Neidhardt, Eve-Marie Péron, Julien Diallo, Alpha Céruse, Philippe 1949-2553 Impact Journals, LLC Oncology http://dx.doi.org/10.18632/oncotarget.8934 Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients Oncotarget
doi_str_mv 10.18632/oncotarget.8934
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTg2MzIvb25jb3RhcmdldC44OTM0
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTg2MzIvb25jb3RhcmdldC44OTM0
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Impact Journals, LLC, 2016
imprint_str_mv Impact Journals, LLC, 2016
issn 1949-2553
issn_str_mv 1949-2553
language English
mega_collection Impact Journals, LLC (CrossRef)
match_str fayette2016neoadjuvantmodifiedtpfdocetaxelcisplatinfluorouracilforpatientsunfittostandardtpfinlocallyadvancedheadandnecksquamouscellcarcinomaastudyof48patients
publishDateSort 2016
publisher Impact Journals, LLC
recordtype ai
record_format ai
series Oncotarget
source_id 49
title Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_unstemmed Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_full Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_fullStr Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_full_unstemmed Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_short Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_sort neoadjuvant modified tpf (docetaxel, cisplatin, fluorouracil) for patients unfit to standard tpf in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
topic Oncology
url http://dx.doi.org/10.18632/oncotarget.8934
publishDate 2016
physical 37297-37304
description
container_issue 24
container_start_page 37297
container_title Oncotarget
container_volume 7
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792344893815783424
geogr_code not assigned
last_indexed 2024-03-01T17:14:40.327Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Neoadjuvant+modified+TPF+%28docetaxel%2C+cisplatin%2C+fluorouracil%29+for+patients+unfit+to+standard+TPF+in+locally+advanced+head+and+neck+squamous+cell+carcinoma%3A+a+study+of+48+patients&rft.date=2016-06-14&genre=article&issn=1949-2553&volume=7&issue=24&spage=37297&epage=37304&pages=37297-37304&jtitle=Oncotarget&atitle=Neoadjuvant+modified+TPF+%28docetaxel%2C+cisplatin%2C+fluorouracil%29+for+patients+unfit+to+standard+TPF+in+locally+advanced+head+and+neck+squamous+cell+carcinoma%3A+a+study+of+48+patients&aulast=C%C3%A9ruse&aufirst=Philippe&rft_id=info%3Adoi%2F10.18632%2Foncotarget.8934&rft.language%5B0%5D=eng
SOLR
_version_ 1792344893815783424
author Fayette, Jérôme, Fontaine-Delaruelle, Clara, Ambrun, Alexis, Daveau, Clémentine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Neidhardt, Eve-Marie, Péron, Julien, Diallo, Alpha, Céruse, Philippe
author_facet Fayette, Jérôme, Fontaine-Delaruelle, Clara, Ambrun, Alexis, Daveau, Clémentine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Neidhardt, Eve-Marie, Péron, Julien, Diallo, Alpha, Céruse, Philippe, Fayette, Jérôme, Fontaine-Delaruelle, Clara, Ambrun, Alexis, Daveau, Clémentine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Neidhardt, Eve-Marie, Péron, Julien, Diallo, Alpha, Céruse, Philippe
author_sort fayette, jérôme
container_issue 24
container_start_page 37297
container_title Oncotarget
container_volume 7
description
doi_str_mv 10.18632/oncotarget.8934
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTg2MzIvb25jb3RhcmdldC44OTM0
imprint Impact Journals, LLC, 2016
imprint_str_mv Impact Journals, LLC, 2016
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1949-2553
issn_str_mv 1949-2553
language English
last_indexed 2024-03-01T17:14:40.327Z
match_str fayette2016neoadjuvantmodifiedtpfdocetaxelcisplatinfluorouracilforpatientsunfittostandardtpfinlocallyadvancedheadandnecksquamouscellcarcinomaastudyof48patients
mega_collection Impact Journals, LLC (CrossRef)
physical 37297-37304
publishDate 2016
publishDateSort 2016
publisher Impact Journals, LLC
record_format ai
recordtype ai
series Oncotarget
source_id 49
spelling Fayette, Jérôme Fontaine-Delaruelle, Clara Ambrun, Alexis Daveau, Clémentine Poupart, Marc Ramade, Antoine Zrounba, Philippe Neidhardt, Eve-Marie Péron, Julien Diallo, Alpha Céruse, Philippe 1949-2553 Impact Journals, LLC Oncology http://dx.doi.org/10.18632/oncotarget.8934 Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients Oncotarget
spellingShingle Fayette, Jérôme, Fontaine-Delaruelle, Clara, Ambrun, Alexis, Daveau, Clémentine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Neidhardt, Eve-Marie, Péron, Julien, Diallo, Alpha, Céruse, Philippe, Oncotarget, Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients, Oncology
title Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_full Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_fullStr Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_full_unstemmed Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_short Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_sort neoadjuvant modified tpf (docetaxel, cisplatin, fluorouracil) for patients unfit to standard tpf in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
title_unstemmed Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
topic Oncology
url http://dx.doi.org/10.18632/oncotarget.8934